TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients

TDP-43 and HERV-K Envelope-Specific Immunogenic Epitopes Are Recognized in ALS Patients

The human endogenous retrovirus-K (HERV-K) and TAR DNA-binding protein 43 (TDP-43) have been associated with the pathophysiology of amyotrophic lateral sclerosis (ALS). Given these findings, we investigated the humoral response against HERV-K envelope surface (env-su) glycoprotein antigens and TDP-4...

Full description

Bibliographic Details
Main Authors:	Elena Rita Simula, Giannina Arru, Ignazio Roberto Zarbo, Paolo Solla, Leonardo A. Sechi
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Viruses
Subjects:	ALS amyotrophic lateral sclerosis TDP-43 HERV-K HML-2
Online Access:	https://www.mdpi.com/1999-4915/13/11/2301

Similar Items

Comprehensive Analysis of HERV Transcriptome in HIV+ Cells: Absence of HML2 Activation and General Downregulation of Individual HERV Loci
by: Nicole Grandi, et al.
Published: (2020-04-01)

HERV-K(HML7) Integrations in the Human Genome: Comprehensive Characterization and Comparative Analysis in Non-Human Primates
by: Nicole Grandi, et al.
Published: (2021-05-01)

TDP-43 pathology is sufficient to drive axon initial segment plasticity and hyperexcitability of spinal motoneurones in vivo in the TDP43-ΔNLS model of Amyotrophic Lateral Sclerosis
by: Svetlana Djukic, et al.
Published: (2025-02-01)

HERV-K Modulates the Immune Response in ALS Patients
by: Giannina Arru, et al.
Published: (2021-08-01)

c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation
by: Saebom Lee, et al.
Published: (2022-12-01)

Cytoplasmic Human TDP-43 Mislocalization Induces Widespread Dendritic Spine Loss in Mouse Upper Motor Neurons
by: Marcus S. Dyer, et al.
Published: (2021-06-01)

TDP-43 Cytoplasmic Translocation in the Skin Fibroblasts of ALS Patients
by: Miguel A. Rubio, et al.
Published: (2022-01-01)

TDP-43 Proteinopathy Specific Biomarker Development
by: Isabell Cordts, et al.
Published: (2023-02-01)

Advancements in TDP-43 research: Towards biomarkers and therapeutic targets for amyotrophic lateral sclerosis
by: Yuhan Wu, et al.
Published: (2025-03-01)

Validation of a newly developed immunoassay for TDP-43 in human plasma
by: Sayo Matsuura, et al.
Published: (2024-01-01)

Liquid–Liquid Phase Separation Enhances TDP-43 LCD Aggregation but Delays Seeded Aggregation
by: Donya Pakravan, et al.
Published: (2021-04-01)

Cyclin F can alter the turnover of TDP-43
by: Stephanie L. Rayner, et al.
Published: (2024-03-01)

Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
by: Rachel H. Tan, et al.
Published: (2023-11-01)

Identification of Genetic Modifiers of TDP-43: Inflammatory Activation of Astrocytes for Neuroinflammation
by: Jae-Hong Kim, et al.
Published: (2021-03-01)

The effect of pH alterations on TDP-43 in a cellular model of amyotrophic lateral sclerosis
by: Yara Al Ojaimi, et al.
Published: (2024-07-01)

CK1δ/ε kinases regulate TDP-43 phosphorylation and are therapeutic targets for ALS-related TDP-43 hyperphosphorylation
by: Vivian I. Ko, et al.
Published: (2024-06-01)

ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice
by: Mai Horiuchi, et al.
Published: (2024-11-01)

A panel of TDP-43-regulated splicing events verifies loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue
by: Maize C. Cao, et al.
Published: (2023-09-01)

TDP-43 dysfunction leads to bioenergetic failure and lipid metabolic rewiring in human cells
by: Miriam Ceron-Codorniu, et al.
Published: (2024-09-01)

TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43
by: Juan M. Godoy-Corchuelo, et al.
Published: (2024-04-01)

Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis
by: Leanne Jiang, et al.
Published: (2022-07-01)

RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
by: Julie C Necarsulmer, et al.
Published: (2023-10-01)

Prion-like Spreading of Disease in TDP-43 Proteinopathies
by: Emma Pongrácová, et al.
Published: (2024-11-01)

The Protective Effect of Edaravone on TDP-43 Plus Oxidative Stress-Induced Neurotoxicity in Neuronal Cells: Analysis of Its Neuroprotective Mechanisms Using RNA Sequencing
by: Aki Soejima-Kusunoki, et al.
Published: (2022-07-01)

Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
by: Maria Tsekrekou, et al.
Published: (2024-05-01)

Neuronal TDP-43 aggregation drives changes in microglial morphology prior to immunophenotype in amyotrophic lateral sclerosis
by: Molly E. V. Swanson, et al.
Published: (2025-02-01)

Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target
by: Gislaine Curty, et al.
Published: (2020-07-01)

Loss of TDP-43 function contributes to genomic instability in amyotrophic lateral sclerosis
by: Minggang Fang, et al.
Published: (2023-10-01)

HERV-K and HERV-H Env Proteins Induce a Humoral Response in Prostate Cancer Patients
by: Maria Antonietta Manca, et al.
Published: (2022-01-01)

Endogenous TDP-43 mislocalization in a novel knock-in mouse model reveals DNA repair impairment, inflammation, and neuronal senescence
by: Joy Mitra, et al.
Published: (2025-03-01)

Epigenetic regulation of TDP-43: potential implications for amyotrophic lateral sclerosis
by: D. Y. Mengistu, et al.
Published: (2025-02-01)

Stress Granule Assembly Can Facilitate but Is Not Required for TDP-43 Cytoplasmic Aggregation
by: Nikita Fernandes, et al.
Published: (2020-09-01)

Synaptic remodeling follows upper motor neuron hyperexcitability in a rodent model of TDP-43
by: Marcus S. Dyer, et al.
Published: (2023-10-01)

Traumatic brain injury induces TDP-43 mislocalization and neurodegenerative effects in tissue distal to the primary injury site in a non-transgenic mouse
by: George R. Bjorklund, et al.
Published: (2023-08-01)

High Expression of HERV-K (HML-2) Might Stimulate Interferon in COVID-19 Patients
by: Yaolin Guo, et al.
Published: (2022-05-01)

The Role of TAR DNA Binding Protein 43 (TDP-43) as a CandiDate Biomarker of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis
by: Caterina Maria Gambino, et al.
Published: (2023-01-01)

Novel in vivo TDP-43 stress reporter models to accelerate drug development in ALS
by: Febe Ferro, et al.
Published: (2024-10-01)

Conditioned Medium from Cells Overexpressing TDP-43 Alters the Metabolome of Recipient Cells
by: Rudolf Hergesheimer, et al.
Published: (2020-09-01)

A Computational Approach to Investigate TDP-43 RNA-Recognition Motif 2 C-Terminal Fragments Aggregation in Amyotrophic Lateral Sclerosis
by: Greta Grassmann, et al.
Published: (2021-12-01)

Respiratory pathology in the TDP-43 transgenic mouse model of amyotrophic lateral sclerosis
by: Debolina D. Biswas, et al.
Published: (2024-08-01)